Send to

Choose Destination
Vaccine. 2001 Aug 14;19(31):4409-16.

Passive transfer of protection against Bacillus anthracis infection in a murine model.

Author information

Pathobiology, CBD, DERA Porton Down, Salisbury, SP4 0JQ, Wiltshire, UK.


Passive transfer of lymphocytes and sera from mice immunised using two different formulations containing recombinant protective antigen (rPA) have been used to further elucidate the mechanism of protection against Bacillus anthracis infection. The results demonstrated that an antibody response maybe important in protection against B. anthracis infection, under the conditions tested. The results provide further data for the development of an improved anthrax vaccine.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center